Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideAPHAmphenol
FinDog View：Neutral
| Metric | APH | NVDA |
|---|
| Close | 77.26 | 213.90 |
| Market Cap | $191B | $5.15T |
| 1M | −9.57% | −4.94% |
| P/E (TTM) | 37.2 | 26.8 |
| Forward P/E | 28.3 | 18.1 |
| P/E 5-Yr Percentile | 100 | 0 |
| P/S | 6.6 | 17.1 |
| P/B | 12.3 | 22.6 |
| Dividend Yield | 0.97% | 0.03% |
| Latest Quarter Revenue | $8.8B | $96.2B |
| Revenue YoY | +55.0% | +105.9% |
| Gross Margin | 40.5% | 75.0% |
| Latest Quarter EPS | 1.37 | 2.46 |
| Avg Post-Earnings Move | ±4.2% | ±3.9% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 4 / 4 |
| Shareholder Yield | 0.91% | 1.20% |
| 90-Day Net Insider Buying | −$180M | −$839M |
APH · Revenue, Last 8 Quarters ($B)
NVDA · Revenue, Last 8 Quarters ($B)
